You are here:Home-Chemical Inhibitors & Agonists-Ras-Raf-MAPK-ERK Pathway-Ras-BI-2865
BI-2865

Chemical Structure : BI-2865

CAS No.: 2937327-93-8

BI-2865 (BI 2865)

Catalog No.: PC-20877Not For Human Use, Lab Use Only.

BI-2865 is a potent, inactive state selective, non-covalent pan KRAS inhibitor, binds to the GDP-loaded state of WT, G12C, G12D, G12V and G13D KRAS with high affinity (ITC Kd values,10-40 nM), inactivates common cancer-causing KRAS mutants.

Packing Price Stock Quantity
2 mg $218 In stock
5 mg $358 In stock
10 mg $558 In stock
25 mg $898 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

BI-2865 is a potent, inactive state selective, non-covalent pan KRAS inhibitor, binds to the GDP-loaded state of WT, G12C, G12D, G12V and G13D KRAS with high affinity (ITC Kd values,10-40 nM), inactivates common cancer-causing KRAS mutants.
BI-2865 inhibits the proliferation of isogenic G12C, G12D or G12V mutant KRAS expressing BaF3 cells with mean IC50 of 140 nM.
BI-2865 shows comparable activity against KRAS G12C-expressing BaF3 cells to that of covalent KRAS G12C inhibitors BI-0474 and sotorasib.
BI-2865 inhibits the activation of KRAS splice variants 4A and 4B with an IC50 of less than 10  nM, with little effect against NRAS and HRAS (IC50=5-10 uM).
BI-2865 treatment inhibited ERK and RSK phosphorylation predominantly in KRAS mutant models (mean IC50 roughly 150 nM for pERK and roughly 70 nM for pRSK), with only a small effect in WT or UAWT models.
BI-2865 suppresses MAPK output more potently in KRAS mutant models correlated, on average, with a more potent antiproliferative effect in a panel of 274 cancer cell lines.

Physicochemical Properties

M.Wt 465.58
Formula C23H27N7O2S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N#CC1=C(N)SC2=C1[C@](C3=NC(C4=NC=CC(O[C@H]([C@H]5N(C)CCC5)C)=N4)=NO3)(C)CCC2

References

1. Dongsung Kim, et al. Nature. 2023 May 31. doi: 10.1038/s41586-023-06123-3.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: